Warts
59
9
10
33
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Published Results
14 trials with published results (24%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 59 trials
100.0%
+13.5% vs benchmark
15%
9 trials in Phase 3/4
42%
14 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (59)
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic
Intralesional HPV Vaccine for Condylomata
Multicenter Real-World Study of Hyperthermia in Warts of Special Population
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
ERAP1,2 in Recalcitrant Warts
Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
Cantharidin and Occlusion in Verruca Epithelium
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts